Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy?

Clinical Neurophysiology

Volumn 113, Issue 3, 2002, Pages 346-353

  Capasso, Margherita ^a   Torrieri, Filomena ^a   Di Muzio, Antonio ^a   De Angelis, Maria Vittoria ^a   Lugaresi, Alessandra ^a   Uncini, Antonino ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Anti myelin associated glycoprotein sulphated glucuronyl paragloboside antibodies; Chronic inflammatory demyelinating polyneuropathy; Conduction block; Proximal conduction time; Sensory conduction; Terminal latency index

Indexed keywords

ANTIBODY; GLUCURONYLPARAGLOBOSIDE ANTIBODY; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN ASSOCIATED GLYCOPROTEIN ANTIBODY; PARAGLOBOSIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ELECTROPHYSIOLOGY; FEMALE; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MOTOR NERVE CONDUCTION; MUSCLE ACTION POTENTIAL; NERVE BLOCK; NERVE POTENTIAL; PERONEUS NERVE; POLYNEUROPATHY; PRIORITY JOURNAL; SENSORY NERVE CONDUCTION; SURAL NERVE;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; DIAGNOSIS, DIFFERENTIAL; ELECTRIC STIMULATION; ELECTRODIAGNOSIS; ELECTROPHYSIOLOGY; FEMALE; GLOBOSIDES; HUMANS; MALE; MIDDLE AGED; MYELIN-ASSOCIATED GLYCOPROTEIN; NEURAL CONDUCTION; PERONEAL NERVE; POLYNEUROPATHIES; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; PREDICTIVE VALUE OF TESTS; REACTION TIME; RETROSPECTIVE STUDIES; SURAL NERVE;

EID: 0036129987     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-2457(02)00011-1     Document Type: Article

References (24)

1. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)
2. Terminal latency index and modified F ratio in distinction of chronic demyelinating neuropathies
3. Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course and recommendations for diagnostic criteria
4. Quantitating severity of neuropathy
5. Permanent axotomy a model of axonal atrophy and secondary segmental demyelination and remyelination
6. Chronic inflammatory demyelinating polyradiculoneuropathy
7. Neuropathy associated with 'benign' anti-myelin-associated glycoprotein IgM gammopathy: Clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases
8. Chronic inflammatory demyelinating polyneuropathy: Clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy
9. Experimental demyelination of nerve induced by serum of patients with neuropathy and anti-MAG IgM M-protein
10. Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside
11. The F wave
12. Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1a antibodies following Campylobacter enteritis
13. Chronic dysimmune demyelinating polyneuropathy: A clinical and electrophysiological study of 93 patients
14. Polyneuropathy and IgM monoclonal gammopathy: Studies on the pathogenetic role of anti-myelin-associated glycoprotein antibody
15. Diagnostic criteria for demyelinating polyneuropathy associated with monoclonal gammopathy
16. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: Comparison of patients without and with monoclonal gammopathy
17. Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy
18. Terminal latency index (TLI) and late response studies in motor neuron disease (MND), peripheral neuropathies and entrapment syndromes
19. Paraproteinaemic neuropathies
20. Experimental paraprotein neuropathy: Demyelination by passive transfer of human anti-myelin-associated glycoprotein
21. Motor conduction parameters in neuropathies associated with anti-MAG antibodies and other types of demyelinating and axonal neuropathies
22. Sensitivity and specificity of diagnostic criteria for conduction block in chronic inflammatory demyelinating polyneuropathy
23. Differential electrophysiological features of neuropathies associated with 17p11.2 deletion and duplication
24. Anti-MAG and anti-SGPG antibodies in neuropathy